CEMTREX INC

For the period ended Mar 31, 2024. Filed May 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 14, 2024

CETX$0.62-2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and September 30, 2023

(Unaudited)
	March 31,	September 30,
	2024	2023
Assets
Current assets
Cash and cash equivalents	$2,916,120	$5,329,910
Restricted cash	1,172,416	1,019,652
Short-term investments	13,853	13,663
Trade receivables, net	11,535,880	9,209,695
Trade receivables, net - related party	1,479,703	1,143,342
Inventory, net	7,397,747	8,739,219
Contract assets, net	1,979,679	1,739,201
Prepaid expenses and other current assets	1,910,415	2,098,359
Total current assets	28,405,813	29,293,041
Property and equipment, net	8,902,051	9,218,701
Right-of-use operating lease assets	2,193,011	2,287,623
Royalties receivable, net - related party	440,049	674,893
Note receivable, net - related party	761,585	761,585
Goodwill	4,381,891	4,381,891
Other	2,161,862	1,836,009
Total Assets	$47,246,262	$48,453,743
Liabilities & Stockholders’ Equity
Current liabilities
Accounts payable	$5,741,091	$6,196,406
Accounts payable - related party	9,214	68,509
Sales tax payable	37,487	35,829
Revolving line of credit	4,019,234	-
Current maturities of long-term liabilities	914,170	14,507,711
Operating lease liabilities - short-term	792,141	741,487
Deposits from customers	207,708	57,434
Accrued expenses	2,676,079	2,784,390
Contract liabilities	1,899,409	980,319
Deferred revenue	1,404,608	1,583,406
Accrued income taxes	404,288	388,627
Total current liabilities	18,105,429	27,344,118
Long-term liabilities
Long-term debt	21,553,920	9,929,348
Long-term operating lease liabilities	1,462,545	1,607,202
Other long-term liabilities	317,093	501,354
Deferred Revenue - long-term	654,617	727,928
Total long-term liabilities	23,988,175	12,765,832
Total liabilities	42,093,604	40,109,950
Commitments and contingencies	-	-
Stockholders’ equity
Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 3,000,000 shares authorized, 2,408,053 shares issued and 2,272,002 shares outstanding as of March 31, 2024 and 2,293,016 shares issued and 2,228,916 shares outstanding as of September 30, 2023 (liquidation value of $10 per share)	2,408	2,293
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at March 31, 2024 and September 30, 2023	50	50
Common stock, $0.001 par value, 50,000,000 shares authorized, 1,055,636 shares issued and outstanding at March 31, 2024 and 1,045,783 shares issued and outstanding at September 30, 2023	1,056	1,046
Additional paid-in capital	68,936,696	68,881,705
Accumulated deficit	(66,806,600)	(64,125,895)
Treasury stock, 136,051 shares of Series 1 Preferred Stock at March 31, 2024 and 64,100 shares of Series 1 Preferred Stock at September 30, 2023	(217,996)	(148,291)
Accumulated other comprehensive income	2,773,784	3,076,706
Total Cemtrex stockholders’ equity	4,689,398	7,687,614
Non-controlling interest	463,260	656,179
Total liabilities and stockholders’ equity	$47,246,262	$48,453,743

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.